New heart failure drug could reduce death by 20 per cent, trial shows
A new drug for heart failure could reduce the number of deaths from the disease by 20%, and is the first treatment in two decades to show a higher survival rate for patients, says one of BC’s top cardiologists.
Dr. Andrew Ignaszewski, head of cardiology at St. Paul’s Hospital, is one of the lead researchers into the largest heart failure study to date and was in Spain on Saturday to present the findings at the European Society of Cardiology.
He called the findings a major advancement in heart failure treatment.
Tiffany Crawford reports
Providence Health Care President and CEO Dianne Doyle